Vaccines: the new Australian best-practice schedule

Margaret A Burgess and Peter B McIntyre
Med J Aust 2004; 180 (10): . || doi: 10.5694/j.1326-5377.2004.tb06050.x
Published online: 17 May 2004

Although some vaccines new to the childhood schedule are not free, they are strongly recommended

  • National Centre for Immunisation Research, Children’s Hospital at Westmead, Sydney, NSW.


  • 1. McIntyre P, Gidding H, Gilmour R, et al. Vaccine preventable diseases and vaccination coverage in Australia, 1999-2000. Commun Dis Intell 2002; 26 Suppl 1: S1-S111.
  • 2. Torvaldsen S, McIntyre PB. The effect of the preschool pertussis booster on national notifications of disease in Australia. Pediatr Infect Dis J 2003; 22: 956-959.
  • 3. Salmaso S, Mastrantonio P, Tozzi AE, et al. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience. Pediatrics 2001; 108: e81.
  • 4. Hethcote HW, Horby P, McIntyre P. Using computer simulations to compare pertussis vaccination strategies in Australia. Vaccine 2004. In press.
  • 5. Gold MS, Noonan S, Osbourn M, et al. Local reactions after the fourth dose of acellular pertussis vaccine in South Australia. Med J Aust 2003; 179: 191-194.
  • 6. Centers for Disease Control and Prevention. Poliomyelitis prevention in the United States: Updated recommendations of the Advisory Committee on Immunisation Practices. MMWR Rec Rep 2000; 49 (RR-5): 1-22.
  • 7. Australian Technical Advisory Group on Immunisation of the Commonwealth Department of Health and Ageing. Australian Immunisation Handbook. 8th edition. Available at: (accessed Dec 2003).
  • 8. Tucker AW, Isaacs D, Burgess M. Cost-effectiveness analysis of changing from live oral poliovirus vaccine to inactivated poliovirus vaccine in Australia. Aust N Z J Public Health 2001; 25: 411-416.
  • 9. Scuffham PA, Lowin AV, Burgess MA. The cost-effectiveness of varicella vaccine programs for Australia. Vaccine 2000; 18: 407-415.
  • 10. Butler JRG, McIntyre P, MacIntyre CR, et al. The cost-effectiveness of pneumococcal conjugate vaccination in Australia. Vaccine 2004; 22: 1138-1149.
  • 11. Lieu T, Cochi SH, Black SB, et al. Cost-effectiveness of a routine varicella vaccination program for US children. JAMA 1994; 271: 375-381.
  • 12. Whitney CG, Farley MM, Hadler J, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003; 348: 1737-1746.
  • 13. Ehreth J. The value of vaccination: a global perspective. Vaccine 2003; 21: 4104-4117.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.